216 related articles for article (PubMed ID: 32905837)
1. Novel monoclonal antibodies targeting the RRM2 domain of human TDP-43 protein.
Trejo-Lopez JA; Sorrentino ZA; Riffe CJ; Lloyd GM; Labuzan SA; Dickson DW; Yachnis AT; Prokop S; Giasson BI
Neurosci Lett; 2020 Nov; 738():135353. PubMed ID: 32905837
[TBL] [Abstract][Full Text] [Related]
2. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R
Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125
[TBL] [Abstract][Full Text] [Related]
3. Ultrastructural localization of TDP-43 in filamentous neuronal inclusions in various neurodegenerative diseases.
Lin WL; Dickson DW
Acta Neuropathol; 2008 Aug; 116(2):205-13. PubMed ID: 18607609
[TBL] [Abstract][Full Text] [Related]
4. Epitope mapping of antibodies against TDP-43 and detection of protease-resistant fragments of pathological TDP-43 in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
Tsuji H; Nonaka T; Yamashita M; Masuda-Suzukake M; Kametani F; Akiyama H; Mann DM; Tamaoka A; Hasegawa M
Biochem Biophys Res Commun; 2012 Jan; 417(1):116-21. PubMed ID: 22133678
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Hasegawa M; Arai T; Nonaka T; Kametani F; Yoshida M; Hashizume Y; Beach TG; Buratti E; Baralle F; Morita M; Nakano I; Oda T; Tsuchiya K; Akiyama H
Ann Neurol; 2008 Jul; 64(1):60-70. PubMed ID: 18546284
[TBL] [Abstract][Full Text] [Related]
6. Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration.
Takeda T
Neuropathology; 2018 Feb; 38(1):72-81. PubMed ID: 28960544
[TBL] [Abstract][Full Text] [Related]
7. TDP-43 proteinopathies: neurodegenerative protein misfolding diseases without amyloidosis.
Kwong LK; Uryu K; Trojanowski JQ; Lee VM
Neurosignals; 2008; 16(1):41-51. PubMed ID: 18097159
[TBL] [Abstract][Full Text] [Related]
8. Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies.
Geser F; Lee VM; Trojanowski JQ
Neuropathology; 2010 Apr; 30(2):103-12. PubMed ID: 20102519
[TBL] [Abstract][Full Text] [Related]
9. Novel monoclonal antibodies to normal and pathologically altered human TDP-43 proteins.
Kwong LK; Irwin DJ; Walker AK; Xu Y; Riddle DM; Trojanowski JQ; Lee VM
Acta Neuropathol Commun; 2014 Mar; 2():33. PubMed ID: 24690345
[TBL] [Abstract][Full Text] [Related]
10. TAR DNA-binding protein 43 in neurodegenerative disease.
Chen-Plotkin AS; Lee VM; Trojanowski JQ
Nat Rev Neurol; 2010 Apr; 6(4):211-20. PubMed ID: 20234357
[TBL] [Abstract][Full Text] [Related]
11. TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease.
Kwong LK; Neumann M; Sampathu DM; Lee VM; Trojanowski JQ
Acta Neuropathol; 2007 Jul; 114(1):63-70. PubMed ID: 17492294
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of thermal unfolding simulations of RNA recognition motifs (RRMs) of TAR DNA-binding protein 43 (TDP-43).
Prakash A; Kumar V; Meena NK; Hassan MI; Lynn AM
J Biomol Struct Dyn; 2019 Jan; 37(1):178-194. PubMed ID: 29279008
[TBL] [Abstract][Full Text] [Related]
13. Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis.
Tan RH; Yang Y; Kim WS; Dobson-Stone C; Kwok JB; Kiernan MC; Halliday GM
Acta Neuropathol Commun; 2017 Oct; 5(1):76. PubMed ID: 29078806
[TBL] [Abstract][Full Text] [Related]
14. Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology.
Kadokura A; Yamazaki T; Lemere CA; Takatama M; Okamoto K
Neuropathology; 2009 Oct; 29(5):566-73. PubMed ID: 19422539
[TBL] [Abstract][Full Text] [Related]
15. [Neurodegenerative disorders and TDP-43].
Nonaka T; Inukai Y; Arai T; Hasegawa M
Brain Nerve; 2009 Feb; 61(2):161-6. PubMed ID: 19235466
[TBL] [Abstract][Full Text] [Related]
16. Znf179 E3 ligase-mediated TDP-43 polyubiquitination is involved in TDP-43- ubiquitinated inclusions (UBI) (+)-related neurodegenerative pathology.
Lee YC; Huang WC; Lin JH; Kao TJ; Lin HC; Lee KH; Lin HC; Shen CJ; Chang WC; Huang CC
J Biomed Sci; 2018 Nov; 25(1):76. PubMed ID: 30404641
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic inclusions of TDP-43 in neurodegenerative diseases: a potential role for caspases.
Rohn TT
Histol Histopathol; 2009 Aug; 24(8):1081-6. PubMed ID: 19554515
[TBL] [Abstract][Full Text] [Related]
18. Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Igaz LM; Kwong LK; Xu Y; Truax AC; Uryu K; Neumann M; Clark CM; Elman LB; Miller BL; Grossman M; McCluskey LF; Trojanowski JQ; Lee VM
Am J Pathol; 2008 Jul; 173(1):182-94. PubMed ID: 18535185
[TBL] [Abstract][Full Text] [Related]
19. TDP-43 in aging and Alzheimer's disease - a review.
Wilson AC; Dugger BN; Dickson DW; Wang DS
Int J Clin Exp Pathol; 2011 Jan; 4(2):147-55. PubMed ID: 21326809
[TBL] [Abstract][Full Text] [Related]
20. Conserved acidic amino acid residues in a second RNA recognition motif regulate assembly and function of TDP-43.
Shodai A; Ido A; Fujiwara N; Ayaki T; Morimura T; Oono M; Uchida T; Takahashi R; Ito H; Urushitani M
PLoS One; 2012; 7(12):e52776. PubMed ID: 23300771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
